Pancreatic kininogenase tablets full name is pancreatic kininogenase enteric-coated tablets, can improve the body circulation, such as due to the need of the disease, long-term standardized use of the general will not be harmful to the body. The main ingredient of pancreatic kininogenase enteric-coated tablets is pancreatic kininogenase, which belongs to vasodilator drugs and can improve body circulation. Mainly used in microcirculation disorders, such as retinopathy, nephropathy caused by diabetes, peripheral neuropathy, etc., pancreatic kininogenase enteric coated tablets need to go through a long-term efficacy in order to see the effect of the long-term standardization of eating is generally not harmful to the body. Although pancreatic kininogenase enteric coated tablets will not harm the body, but cerebral hemorrhage and other bleeding disorders in the acute phase of the patient is prohibited, because pancreatic kininogenase enteric coated tablets to improve circulation will reduce blood viscosity to prevent platelet aggregation, increasing the risk of bleeding. Adverse reactions to pancreatic kininogenase enteric coated tablets are rare, occasionally rash, skin itching, stomach upset and tiredness, etc., disappear after stopping the drug. Pancreatic kininogenase enteric-coated tablets should be taken in accordance with the doctor’s instructions for long-term use, do not use the drug privately, so as not to cause serious consequences.